GlassScriptPhysician profile
Maciej Poltorak
NPI 1427064229
$11,004.87
in general payments reported to CMS, 2019-2025
50 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,561 · 2020: $1,859 · 2021: $1,678 · 2022: $1,645 · 2023: $1,695 · 2024: $958 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,249 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,248.63 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,473.21 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $1,316.99 | 2019-2025 | |
| Abbvie INC. | $1,160.06 | 2019-2025 | |
| Ucb, INC. | $802.66 | 2019-2025 | Briviact |
| Amgen INC. | $797.14 | 2019-2025 | Uplizna |
| Biogen, INC. | $723.30 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Sunovion Pharmaceuticals INC. | $531.25 | 2019-2022 | |
| Allergan, INC. | $393.34 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $295.78 | 2023-2024 | Aptiom |
| Genzyme Corporation | $285.22 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $273.21 | 2020-2025 | Acthar |
| Emd Serono, INC. | $241.91 | 2019-2021 | |
| Horizon Therapeutics Plc | $218.48 | 2021-2023 | Uplizna |
| Neurocrine Biosciences, INC. | $210.09 | 2019-2025 | Ingrezza, Ongentys |
| Celgene Corporation | $200.43 | 2020-2023 | Zeposia |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maciej Poltorak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.